BRIEF-Critical Outcome Activates Second Clinical Trial Site for Its COTI-2 Gynecological Cancer Study

Mon Jun 6, 2016 8:50am EDT
 
Email This Article |
Share This Article
  • Facebook
  • LinkedIn
  • Twitter
| Print This Article
[-] Text [+]

June 6 (Reuters) - Critical Outcome Technologies Inc :

* Critical Outcome Activates Second Clinical Trial Site for Its COTI-2 Gynecological Cancer Study Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1 646 223 8780)